Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Trading Statement

4 Jan 2007 07:00

Tarsus Group PLC04 January 2007 4 January 2007 TARSUS GROUP PLC TRADING UPDATE Tarsus Group PLC ("Tarsus" or "the Group"), the international media group withinterests in exhibitions, conferences, publishing and online media has continuedto trade well in the second half of 2006. Trading for the full year remains inline with Directors' expectations notwithstanding significant US Dollar weaknessin the second half of our financial year. Like-for-like organic revenue growth was a healthy 14%, led by 2 of the Group'slargest events during the year - Labelexpo Americas and Heavent (France) - whichtraded above this overall level. The August Off-Price show once again producedrecord revenues which were slightly ahead of the 2005 result. Generally,attendances at our events in the second half were strong, particularly in Francewhich is benefiting from an improving economic environment. Revenues from emerging markets doubled on a like-for-like basis. We havecontinued to develop our Chinese portfolio throughout 2006 and expect this to bean area of further development in 2007. Caroo - our online business - trebled its revenues, boosted by the acquisitionsof Onrec and TSNN.com. Annualised revenues at Caroo are now running atapproximately £2 million. Elsewhere, Labels and Labelling magazine had anothergood year with revenues up by 10%. Our organic growth strategy has been supplemented by a small number of focusedacquisitions. In October we acquired Proseg, the leading annual facilitiesmanagement exhibition in Paris and then, in November, we announced the purchaseof 80% of Medical Conferences International Inc. (MCII). This was accompanied bya vendor placing of 5.3 million new ordinary shares at 207p, raisingapproximately £10.5 million after expenses. MCII is the leading anti-ageing andregenerative medicine conference and exhibition in the United States with annualevents in Las Vegas, Orlando and Chicago. A number of joint ventures toreplicate the event outside of the United States have been agreed for 2007. TheDecember Las Vegas event produced a strong performance with revenues andattendees up by 55% and 34% respectively, both slightly ahead of ourexpectations at the time of acquisition. Integration is proceeding well. MCII creates a fifth major division to our business and further adds to theorganic growth capability of the Group. Outlook for 2007 The broadening of the Group's base is an important step in underpinning ourability to grow consistently in the years ahead. For 2007, we expect continuedgood levels of organic growth in our portfolio as a result of the increasedlevel of new product development that we have undertaken in the last two years,as well as from the recent acquisitions that we have completed. In 2007, our Labelexpo exhibition returns to Europe and, as a result, we expectour US$ denominated earnings to be nearer 50% of the Group's total earningscompared with approximately 90% in 2006. Forward booking for this - our largestsingle event - are strong. The underlying momentum of the business is positive and we continue to generatestrong cash flows which are being reinvested for further growth. Although we areat a very early stage of the year, the Directors are confident that 2007 will beanother year of strong progress for the Group. Ends For further information please contact: Tarsus Group plc: Douglas Emslie Group Managing Director: Tel 020 8846 2700 Media: Matthew Moth Madano Partnership: Tel: 020 7593 4000 Investors: Neville Harris IRFocus: Tel: 020 7593 4215 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th May 20197:00 amRNSTrading Update
9th May 20196:19 pmRNSBlock Listing Six Monthly Return
30th Apr 201910:14 amRNSTotal Voting Rights
16th Apr 20192:40 pmRNSDirector/PDMR Shareholding
2nd Apr 20193:43 pmRNSBlock listing Interim Review
1st Apr 201910:44 amRNSTotal Voting Rights
19th Mar 201911:42 amRNS2018 Annual Report
8th Mar 20194:36 pmRNSPrice Monitoring Extension
27th Feb 20197:00 amRNSFinal Results
6th Feb 20194:35 pmRNSPrice Monitoring Extension
31st Jan 201911:53 amRNSTotal Voting Rights
30th Jan 20197:00 amRNSOption agreement re Tarsus Connect
16th Jan 20194:22 pmRNSApplication for Admission
14th Jan 20197:00 amRNSYear-end Trading Update
13th Dec 20184:48 pmRNSScrip Dividend Circular (the "Circular")
30th Nov 20183:10 pmRNSTotal Voting Rights
20th Nov 20181:44 pmRNSApplication for Admission
6th Nov 20187:00 amRNSCapital Markets Seminar and Trading Update
1st Nov 20182:56 pmRNSTotal Voting Rights
18th Sep 20186:20 pmRNSDirector/PDMR Shareholding
14th Sep 201812:06 pmRNSResults of Placing
14th Sep 20187:00 amRNSAcquisitions and Placing of New Ordinary Shares
10th Sep 20183:18 pmRNSBlock Listing Six Monthly Return
31st Aug 20183:39 pmRNSTotal Voting Rights
24th Aug 201811:17 amRNSHalf-year Report
1st Aug 201811:54 amRNSTotal Voting Rights
26th Jul 20187:00 amRNSHalf-year Report
13th Jul 20182:34 pmRNSApplication for Admission - scrip dividend shares
13th Jul 20182:18 pmRNSDirector Declaration
21st Jun 20181:52 pmRNSResult of AGM
18th Jun 20183:37 pmRNSHolding(s) in Company
12th Jun 20184:41 pmRNSDirector/PDMR Shareholding
8th Jun 20183:45 pmRNSScrip Dividend Circular
1st Jun 201812:31 pmRNSTotal Voting Rights
21st May 20186:10 pmRNSNotice of AGM
17th May 20187:00 amRNSTrading Update
9th May 20187:00 amRNSBoard Changes
9th May 20187:00 amRNSBlock Listing Six Monthly Return
1st May 201811:45 amRNSTotal Voting Rights and Capital
20th Apr 201812:15 pmRNSDirector/PDMR Shareholding
20th Apr 201812:14 pmRNSDirector/PDMR Shareholding
18th Apr 20184:29 pmRNSNotification of Transactions
29th Mar 201810:50 amRNSTotal Voting Rights
22nd Mar 20185:01 pmRNS2017 Annual Report
9th Mar 20183:54 pmRNSDirector/PDMR Shareholding
6th Mar 201810:18 amRNSBlock Listing Six Monthly Return
5th Mar 20185:06 pmRNSDirector/PDMR Shareholding
28th Feb 20187:00 amRNSFinal Results
31st Jan 20189:40 amRNSTotal Voting Rights
12th Jan 201810:30 amRNSApplication for Admission - scrip dividend shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.